Recombinant Drosophila simulans Eukaryotic translation initiation factor 3 subunit A (eIF3-S10), partial

Shipped with Ice Packs
In Stock

Description

Definition and Molecular Classification

eIF3-S10 (eIF3a) is a core subunit of the eukaryotic initiation factor 3 (eIF3) complex, essential for translation initiation. The recombinant "partial" designation indicates that the protein is produced using recombinant DNA technology and lacks certain regions of the full-length sequence, often to facilitate experimental manipulation or structural studies .

Functional Contributions:

  • Ribosome Binding: Direct interaction with the 40S subunit’s solvent face near mRNA entry/exit channels .

  • mRNA Recruitment: Facilitates binding of mRNA to the PIC via interactions with eIF4G and 5’-UTR elements .

  • Scanning Regulation: Modulates ribosomal scanning efficiency and start-codon recognition .

Recombinant Production and Applications

Recombinant eIF3-S10 is typically expressed in insect or mammalian cell systems to preserve post-translational modifications. Partial constructs often exclude flexible or non-essential regions (e.g., C-terminal segments) to improve solubility and crystallography outcomes .

Example Production Workflow (Based on Mammalian Systems7):

StepDescriptionYield/Outcome
1. CloningCodon-optimized eIF3a gene inserted into baculovirus vectorN/A
2. ExpressionExpressed in Sf9 insect cells with FLAG-tag purification~80 μg per 3L culture
3. Functional AssayRibosome-binding toeprinting confirms 60–70% activity vs. native eIF3Partial complexes retain core functionality

Comparative Analysis of eIF3a Across Species

The table below highlights eIF3a conservation and essentiality in model organisms :

SpeciesSubunit NameMolecular Weight (kDa)EssentialityHuman Ortholog Identity
D. melanogastereIF3-S10114Yes44%
H. sapienseIF3A166.6Yes
S. cerevisiaeTIF32110.3Yes28%

Research Findings and Implications

  • Mitochondrial Translation: eIF3a supports translation of mRNAs encoding oxidative phosphorylation components, linking its activity to cellular energy metabolism .

  • Disease Relevance: Truncated eIF3 subunits (e.g., murine eIF3e) are implicated in tumorigenesis via dysregulated HIF2α signaling , suggesting analogous roles for eIF3a perturbations.

  • Structural Flexibility: Cryo-EM studies reveal that eIF3a’s spectrin domain acts as a "mechanical arm," adjusting its position during ribosomal scanning .

Open Questions and Future Directions

  • How do partial eIF3-S10 constructs affect the stability of the eIF3 complex in Drosophila?

  • Does D. simulans eIF3a exhibit species-specific regulatory roles compared to D. melanogaster?

  • Can recombinant eIF3-S10 be used to study translation dysregulation in neurodegenerative models?

Product Specs

Form
Lyophilized powder. We will ship the available format, but please note any format requirements when ordering, and we will try to accommodate them.
Lead Time
Delivery times vary by purchase method and location. Please consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. Contact us in advance for dry ice shipping (additional fees apply).
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during production. If you require a specific tag, please let us know and we will prioritize its development.
Synonyms
eIF3a; eIF3-S10; GD19678Eukaryotic translation initiation factor 3 subunit A; eIF3a; Eukaryotic translation initiation factor 3 subunit 10
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Drosophila simulans (Fruit fly)
Target Names
Uniprot No.

Target Background

Function
eIF3-S10 is an RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex. This complex plays a role in the translation of specific mRNAs and, along with other initiation factors, facilitates the binding of mRNA and methionyl-tRNAi to the 40S ribosome. The eIF-3 complex specifically targets and initiates the translation of a subset of mRNAs involved in cell proliferation.
Protein Families
EIF-3 subunit A family
Subcellular Location
Cytoplasm.

Q&A

What is eIF3a/eIF3-S10 and what is its primary function in Drosophila?

eIF3a, also called eIF3-S10, p150, or p170, is a component of the eukaryotic translation initiation factor 3 (eIF3) complex. In Drosophila, as in other eukaryotes, eIF3a participates in forming the translation preinitiation complex and prevents premature binding of the 40S to the 60S ribosomal subunits . eIF3 is the largest and most complex eIF, with a modular structure that plays multiple roles not only in translation initiation but also in termination, ribosomal recycling, and stop codon readthrough . Though not all eIF3a is associated with ribosomes, indicating it may have functions beyond protein translation, its primary role remains facilitating the assembly of the translation machinery .

How does the protein structure of Drosophila eIF3a compare to mammalian homologs?

Drosophila eIF3a shares significant structural homology with mammalian eIF3a, particularly in the conserved domains responsible for interaction with other eIF3 subunits and the translation machinery. Both contain PCI (Proteasome, COP9, eIF3) domains that form a structural scaffold with other eIF3 subunits (a, c, e, f, h, k, l, and m) . While the core functional domains are conserved across species, there are species-specific variations in regulatory regions that may account for differences in interaction partners and regulatory mechanisms. These structural similarities enable functional studies in Drosophila to provide insights applicable to understanding mammalian translation regulation systems.

What is the recommended protocol for reconstitution of recombinant Drosophila eIF3-S10?

For optimal reconstitution of recombinant Drosophila eIF3-S10, the lyophilized protein should first be briefly centrifuged to bring contents to the bottom of the vial. Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL . The addition of glycerol to a final concentration of 5-50% is recommended for long-term storage, with 50% being the default concentration for maximum stability . After reconstitution, the protein should be aliquoted to avoid repeated freeze-thaw cycles and stored at -20°C or -80°C. For working stocks, store aliquots at 4°C for up to one week .

How does eIF3a contribute to cellular proliferation in model organisms?

eIF3a regulates cell cycle progression and proliferation by controlling the translation of specific mRNAs encoding cell cycle regulators. Studies have shown that eIF3a can control the translation of mRNAs encoding the cell cycle inhibitor p27Kip1 and the M2 subunit of ribonucleotide reductase, a rate-limiting enzyme in DNA synthesis . Overexpression of eIF3a can transform NIH 3T3 cells by enhancing global protein synthesis and particularly the synthesis of proteins that stimulate proliferation, such as cyclin D1, c-Myc, fibroblast growth factor 2, and ornithine decarboxylase . In Drosophila models, similar mechanisms likely operate, making eIF3a an important factor in developmental and proliferative processes.

How can RNA interference be optimized to study eIF3a function in Drosophila cell lines?

For effective RNAi-mediated knockdown of eIF3a in Drosophila cell lines, researchers should design multiple siRNA sequences targeting different regions of the eIF3a transcript to ensure efficient silencing. Based on protocols used in mammalian systems, transfection of 20-50 nM siRNA typically yields optimal knockdown with minimal off-target effects . When designing experiments:

  • Include appropriate negative controls (non-targeting siRNA) and positive controls (siRNA targeting a gene with known phenotype)

  • Validate knockdown efficiency by both qPCR (to assess mRNA levels) and Western blotting (to confirm protein reduction)

  • Perform time-course studies to determine optimal time points for analysis (typically 48-72 hours post-transfection)

  • Use multiple cell lines when possible to account for cell type-specific effects

For phenotypic analysis following eIF3a knockdown, assess translation efficiency through polysome profiling, which can reveal defects in translation initiation marked by changes in polysome content and 80S monosome peaks .

What approaches can be used to study the interactome of Drosophila eIF3a?

To comprehensively map the Drosophila eIF3a interactome, researchers should employ multiple complementary approaches:

TechniqueApplicationAdvantagesLimitations
Co-immunoprecipitation (Co-IP)Identify stable protein-protein interactionsCan detect native complexesMay miss transient interactions
Proximity labeling (BioID/TurboID)Identify both stable and transient proximitiesMaps spatial relationshipsPotential false positives
Yeast two-hybrid screeningScreen for direct binary interactionsHigh-throughput capabilityHigh false-positive rate
Mass spectrometryIdentify complex componentsUnbiased, comprehensiveRequires careful controls
Cross-linking MSCapture transient interactionsMaps interaction interfacesTechnical complexity

Based on studies in mammalian systems, eIF3a has been shown to interact with signaling proteins like SHC and Raf-1 , cytoskeletal components including actin , and other eIF3 subunits. Experiments should be designed to validate whether these interactions are conserved in Drosophila systems, especially focusing on the β-arrestin2-mediated enhancement of the eIF3a-Raf-1 interaction, which has significant implications for ERK pathway regulation .

What methodology should be used to assess the impact of eIF3a mutations on the Drosophila translatome?

To comprehensively assess how eIF3a mutations affect the Drosophila translatome, researchers should implement a Ribo-Seq approach coupled with RNA-Seq, similar to methodologies used in human cells . This approach allows for genome-wide analysis of translational efficiency (TE) and identification of differentially translated mRNAs. The experimental workflow should include:

  • Generate eIF3a mutant Drosophila cell lines or transgenic flies using CRISPR/Cas9 or RNAi

  • Prepare samples for both Ribo-Seq (to measure ribosome-protected fragments) and RNA-Seq (to quantify mRNA abundance)

  • Calculate translation efficiency (TE) by normalizing Ribo-Seq reads to RNA-Seq reads

  • Identify differentially translated genes (DTEGs) using statistical algorithms

  • Perform 5' UTR analysis to identify regulatory elements affected by eIF3a mutation

Special attention should be paid to mRNAs with complex 5' UTRs, particularly those containing upstream open reading frames (uORFs), as changes in eIF3 stoichiometry have been shown to affect the translation of these transcripts in human cells .

How does eIF3a regulate the ERK signaling pathway in Drosophila compared to mammals?

eIF3a regulates the ERK signaling pathway through direct protein-protein interactions with pathway components. In mammalian systems, eIF3a has been shown to bind to SHC and Raf-1, two key components of the ERK pathway . The interaction between eIF3a and Raf-1 is enhanced by β-arrestin2 expression and transiently decreased by EGF stimulation, with the decrease kinetically correlating with ERK activation .

In Drosophila, while the exact mechanism may have species-specific variations, the core regulatory principles likely remain conserved given the high conservation of both eIF3a and the ERK pathway across species. The functional impact appears similar: eIF3a interferes with Raf-1 activation, and its downregulation enhances ERK activation, early gene expression, and cellular responses dependent on ERK signaling .

This regulatory mechanism represents a novel connection between translational machinery and signal transduction that may be particularly important during developmental processes in Drosophila, where both translation regulation and ERK signaling play critical roles.

What experimental designs can detect changes in signaling pathway activation following eIF3a manipulation?

To effectively detect changes in signaling pathway activation following eIF3a manipulation in Drosophila systems, researchers should implement multi-layered experimental designs:

  • Phosphorylation assays: Monitor the phosphorylation status of key ERK pathway components (particularly ERK itself and its upstream activators MEK and Raf-1) using phospho-specific antibodies in Western blotting. Time-course experiments following stimulation (e.g., with EGF or other growth factors) are essential to capture the altered kinetics of pathway activation .

  • Reporter gene assays: Implement pathway-specific transcriptional reporters (like ERK-responsive promoters driving luciferase expression) to quantitatively assess downstream transcriptional outputs.

  • Target gene expression analysis: Measure the expression of known ERK pathway target genes (e.g., c-Fos) using qPCR or RNA-Seq to assess transcriptional consequences .

  • Phenotypic assays: Depending on the cell type, measure relevant cellular responses like proliferation (using BrdU incorporation), differentiation (in appropriate models like PC12 cells), or cellular transformation (using focus formation assays) .

  • Genetic interaction studies: In Drosophila models, combine eIF3a manipulation with genetic perturbations of ERK pathway components to assess epistatic relationships.

How do alterations in eIF3a expression affect stress response pathways in cellular models?

Alterations in eIF3a expression significantly impact stress response pathways through both direct signaling regulation and translational control mechanisms. When eIF3a levels are reduced:

  • Enhanced stress pathway activation: Reduced eIF3a leads to prolonged ERK activation following stimulation, which can enhance cellular stress responses .

  • Altered translation of stress-responsive mRNAs: eIF3a depletion affects the translation efficiency of mRNAs containing complex 5' UTRs, particularly those with uORFs like the stress-responsive transcription factor ATF4 .

  • Changed translation of TOP mRNAs: Depletion of eIF3 subunits (particularly eIF3e and partially eIF3d) increases translation of 5' terminal oligopyrimidine (TOP) mRNAs that encode components of the translational machinery, affecting the cell's capacity to respond to stress .

  • Modified ribosome recycling: As eIF3 plays roles in ribosomal recycling, altered eIF3a levels may impact the efficiency of translation reinitiation during stress conditions .

These effects collectively modify the cell's adaptive responses to various stressors, including oxidative stress, nutrient deprivation, and protein misfolding, with potentially significant consequences for cellular survival and homeostasis in Drosophila models.

How conserved is eIF3a structure and function between Drosophila simulans and other Drosophila species?

eIF3a structure and function show strong conservation across Drosophila species, reflecting the fundamental importance of translation initiation mechanisms. Protein sequence analysis reveals high homology in functional domains between D. simulans and other Drosophila species, particularly D. melanogaster and D. persimilis . Core functional regions, including those mediating interactions with other eIF3 subunits and the translation machinery, demonstrate >90% sequence identity.

What insights can Drosophila eIF3a studies provide for understanding human disease mechanisms?

Studies of Drosophila eIF3a can provide valuable insights into human disease mechanisms through several parallel research avenues:

  • Cancer biology: eIF3a overexpression has been implicated in transformation and enhanced proliferation in mammalian cells . Drosophila models can help elucidate the mechanistic basis of how altered eIF3a levels contribute to dysregulated growth and potential oncogenic transformation.

  • Neurodevelopmental disorders: The interaction between eIF3a and signaling pathways like ERK, which are critical for neuronal differentiation , suggests that Drosophila studies may illuminate mechanisms underlying neurodevelopmental disorders associated with translational dysregulation.

  • Stress response pathologies: eIF3a's role in regulating stress-responsive transcripts makes Drosophila models valuable for understanding human diseases involving impaired stress adaptation, including neurodegenerative conditions and metabolic disorders.

  • Drug development platforms: Drosophila eIF3a studies can help identify potential therapeutic targets within the translation machinery, especially for diseases where aberrant translation of specific mRNAs drives pathology.

The genetic tractability of Drosophila allows for rapid in vivo validation of disease mechanisms identified in mammalian cell culture, providing an important bridge between cellular and mammalian model systems.

How do post-translational modifications of eIF3a differ across species and what are their functional implications?

Post-translational modifications (PTMs) of eIF3a exhibit both conserved and species-specific patterns across evolutionary lineages, with significant functional implications:

PTM TypeConservation StatusFunctional Implications
PhosphorylationHighly conserved sites at Ser/Thr residuesRegulates interaction with signaling components like Raf-1; modulates ERK pathway regulation
UbiquitinationModerately conservedControls protein stability and turnover during stress responses
SUMOylationVariable across speciesMay affect nuclear-cytoplasmic distribution and non-canonical functions
AcetylationSome conserved sitesPotentially regulates interaction with specific mRNA targets

In Drosophila, the phosphorylation status of eIF3a likely regulates its interaction with signaling components, similar to what has been observed in mammalian systems where the eIF3a-Raf-1 interaction is modulated by phosphorylation events . These modifications provide a molecular mechanism for integrating external signals with translational control, allowing for rapid adaptation to changing cellular environments.

Species-specific PTM patterns may contribute to differences in how translation regulation is coupled to developmental programming and environmental response across different organisms, making comparative studies of eIF3a PTMs valuable for understanding the evolution of translational control mechanisms.

What are the most common challenges in expressing and purifying recombinant Drosophila eIF3a?

Researchers commonly encounter several challenges when expressing and purifying recombinant Drosophila eIF3a:

How can researchers effectively validate the functional activity of recombinant eIF3a protein?

To effectively validate the functional activity of recombinant Drosophila eIF3a, researchers should employ a multi-faceted approach:

  • In vitro translation assays: Test the ability of purified eIF3a to complement eIF3a-depleted cell extracts in supporting translation of reporter mRNAs. This approach directly assesses the protein's capacity to function in translation initiation.

  • Binding assays with known interaction partners: Perform pull-down or surface plasmon resonance (SPR) experiments to confirm binding to known partners such as other eIF3 subunits, Raf-1, or SHC proteins . Proper binding kinetics indicate correctly folded and functional protein.

  • Rescue experiments: Introduce recombinant eIF3a into eIF3a-knockdown cells and assess rescue of phenotypes such as translation defects (measured by polysome profiling) or alterations in ERK pathway activation .

  • Structural characterization: Circular dichroism (CD) spectroscopy can provide information about secondary structure content, while limited proteolysis can help assess proper domain folding by producing characteristic fragment patterns.

  • Functional domain mapping: Generate truncated versions or point mutants of eIF3a to verify that specific functions map to the expected domains, such as the D608N mutation that enhances phosphotyrosine-directed activity in phosphatases , which could provide insight for analogous mutations in eIF3a functional studies.

What controls are essential when studying eIF3a-mediated effects on mRNA translation?

When studying eIF3a-mediated effects on mRNA translation, several essential controls must be implemented to ensure reliable and interpretable results:

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.